Shahla Masood, M.D.

Shahla Masood M.D.

Professor & Chair, Department of Pathology and Laboratory Medicine; Program Director, Breast Pathology Fellowship; Medical Director, Breast Health Center; Program Director, Cytopathology Fellowship; Director of Research; Interim Director of Cancer Programs

Department: Department of Pathology and Laboratory Medicine
Business Phone: (904) 244-7815
Business Email: shahla.masood@jax.ufl.edu
Appointments and Locations

Board Certifications

  • Pathology - Anatomic and Clinical
  • Cytopathology

Clinical Profile

Specialties
  • Cytopathology
  • Pathology - Anatomic and Clinical
Interests
  • Clinical Special Interests: Breast pathology, cytopathology
  • Research Special Interests: Early breast cancer detection; use of minimally invasive procedures to provide optimal samples for analysis; prognostic/predictive index

Publications

2022
Associations of Computed Tomography Image-Assessed Adiposity and Skeletal Muscles with Triple-Negative Breast Cancer.
Cancers.14(7):-[DOI] 10.3390/cancers14071846.[PMID] 35406618.
1 citations·PubMed·Publisher's Site
2022
Intraindividual Reliability of Opportunistic Computed Tomography-Assessed Adiposity and Skeletal Muscle Among Breast Cancer Patients.
JNCI cancer spectrum.6(6):-[DOI] 10.1093/jncics/pkac068.[PMID] 36222575.
PubMed·Publisher's Site
2022
Toward realization of remote controlled telecytopathology-a validation study from a large academic medical center from the southeast United States.
Journal of the American Society of Cytopathology.11(5):320-327[DOI] 10.1016/j.jasc.2022.04.003.[PMID] 35589507.
PubMed·Publisher's Site
2021
Changing the philosophy, direction, and the governance of The Breast Journal as it moves towards becoming an "Open Access" journal in 2022.
The breast journal.27(1):5-6[DOI] 10.1111/tbj.14145.[PMID] 33368841.
1 citations·PubMed·Publisher's Site
2021
Farewell to The Breast Journal: A novel scientific publication led by a pathologist who moved beyond the microscope and faced the patients.
The breast journal.27(12):849-850[DOI] 10.1111/tbj.14304.[PMID] 34897874.
PubMed·Publisher's Site
2021
Prediction and assessment of response to neo-adjuvant chemotherapy in breast cancer: The responsibilities of breast pathologists.
The breast journal.27(8):629-630[DOI] 10.1111/tbj.14274.[PMID] 34331376.
1 citations·PubMed·Publisher's Site
2021
The continued role of intraoperative assessment of the surgical margins in lumpectomy samples.
The breast journal.27(11):795-796[DOI] 10.1111/tbj.14298.[PMID] 34761478.
PubMed·Publisher's Site
2021
The significance of accurate diagnosis of encapsulated papillary carcinoma of the breast by core needle biopsy.
The breast journal.27(3):207-208[DOI] 10.1111/tbj.14220.[PMID] 33723925.
PubMed·Publisher's Site
2021
This is Not Only about the Biology: The Socioeconomic Disparities among African American Women with Breast Cancer Still Play a Significant Role.
The breast journal.27(7):571-572[DOI] 10.1111/tbj.14263.[PMID] 34145683.
PubMed·Publisher's Site
2021
Why proper characterization of breast cancer subtypes makes a difference in patient care.
The breast journal.27(9):689-690[DOI] 10.1111/tbj.14285.[PMID] 34431163.
PubMed·Publisher's Site
2021
Why women with an average risk for breast cancer undergo contralateral breast mastectomy? Does healthcare coverage matter?
The breast journal.27(10):743-745[DOI] 10.1111/tbj.14293.[PMID] 34582066.
PubMed·Publisher's Site
2020
Breast cancer risk assessment and management.
The breast journal.26(8):1505-[DOI] 10.1111/tbj.14013.[PMID] 32783316.
PubMed·Publisher's Site
2020
Breast cancer treatment: A phased approach to implementation.
Cancer.126 Suppl 10():2365-2378[DOI] 10.1002/cncr.32910.[PMID] 32348571.
35 citations·PubMed·Publisher's Site
2020
Breast pathology: The core of an integrated practice of personalized breast care.
The breast journal.26(6):1121-1122[DOI] 10.1111/tbj.13873.[PMID] 32372475.
PubMed·Publisher's Site
2020
Celebrating a "Quarter of Century" contributions of The Breast Journal.
The breast journal.26(1):4-[DOI] 10.1111/tbj.13727.[PMID] 31957908.
2 citations·PubMed·Publisher's Site
2020
Is it ductal carcinoma in situ with microinvasion or "Ductogenesis"? The role of myoepithelial cell markers.
The breast journal.26(6):1138-1147[DOI] 10.1111/tbj.13897.[PMID] 32447817.
PubMed·Publisher's Site
2020
Is it time to address the continuous dilemma of breast cancer disparities among African Americans? A call to action.
The breast journal.26(12):2339-2340[DOI] 10.1111/tbj.14124.[PMID] 33283942.
2 citations·PubMed·Publisher's Site
2020
The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview.
Cancer.126 Suppl 10(Suppl 10):2339-2352[DOI] 10.1002/cncr.32891.[PMID] 32348573.
35 citations·PubMed·Publisher's Site
2020
The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
The breast journal.26(1):27-34[DOI] 10.1111/tbj.13728.[PMID] 31876097.
2 citations·PubMed·Publisher's Site
2020
The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer.
The breast journal.26(8):1583-1588[DOI] 10.1111/tbj.14012.[PMID] 32845077.
1 citations·PubMed·Publisher's Site
2020
Ultrastructural Characteristics of Gallbladder Epithelial Inclusions Mimicking Cystoisospora.
American journal of clinical pathology.153(1):88-93[DOI] 10.1093/ajcp/aqz137.[PMID] 31600399.
3 citations·PubMed·Publisher's Site
2019
Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
The breast journal.25(4):575-577[DOI] 10.1111/tbj.13292.[PMID] 31280501.
2 citations·PubMed·Publisher's Site
2016
Breast cancer subtypes: morphologic and biologic characterization.
Women's health (London, England).12(1):103-19[DOI] 10.2217/whe.15.99.[PMID] 26756229.
23 citations·PubMed·Publisher's Site
2016
DNA Methylation of the hTERT Gene in Breast Cancer Revisited: Diagnostic and Clinical Implications.
Laboratory medicine.47(4):293-299[DOI] .[PMID] 27708168.
3 citations·PubMed·Publisher's Site
2016
Moving toward appropriateness of breast cancer care: a balanced act to redefine the scope of standard of care.
Women's health (London, England).12(2):163-6[DOI] 10.2217/whe-2015-0002.[PMID] 26901376.
3 citations·PubMed·Publisher's Site
2016
Neoadjuvant chemotherapy in breast cancers.
Women's health (London, England).12(5):480-491[DOI] .[PMID] 27885165.
48 citations·PubMed·Publisher's Site
2016
The potential of identification of a malignancy-associated biomarker in breast cancer diagnosis and research: hTERT gene DNA methylation.
Diagnostic cytopathology.44(8):670-5[DOI] 10.1002/dc.23505.[PMID] 27229911.
3 citations·PubMed·Publisher's Site
2015
Comparative cost-effectiveness of fine needle aspiration biopsy versus image-guided biopsy, and open surgical biopsy in the evaluation of breast cancer in the era of Affordable Care Act: a changing landscape.
Diagnostic cytopathology.43(8):605-12[DOI] 10.1002/dc.23270.[PMID] 25722099.
13 citations·PubMed·Publisher's Site
2015
Cytologic features of metanephric adenoma of the kidney: case report and review of the literature.
Laboratory medicine.46(2):153-8; quiz e30[DOI] 10.1309/LMW2MHDM6EILGQH2.[PMID] 25918196.
2 citations·PubMed·Publisher's Site
2015
Development of a novel approach for breast cancer prediction and early detection using minimally invasive procedures and molecular analysis: how cytomorphology became a breast cancer risk predictor.
The breast journal.21(1):82-96[DOI] 10.1111/tbj.12362.[PMID] 25556774.
4 citations·PubMed·Publisher's Site
2015
Diagnostic value and accuracy of imprint cytology evaluation during image-guided core needle biopsies: Review of our experience at a large academic center.
Diagnostic cytopathology.43(10):773-9[DOI] 10.1002/dc.23300.[PMID] 26119885.
20 citations·PubMed·Publisher's Site
2015
Htert Gene Expression and Dna Methylation in Breast Cancer Revisited By Realtime Rt-Pcr and Methylation Specific Pcr
Laboratory Investigation.95(1):72A-73A[DOI] .[PMID] .
PubMed·Publisher's Site
2015
Is digoxin a breast cancer risk factor?
Acute cardiac care.17(2):29-31[DOI] 10.3109/17482941.2015.1066823.[PMID] 26458027.
1 citations·PubMed·Publisher's Site
2015
Minimizing Errors in Breast Pathology: A Call for Action.
The breast journal.21(4):333-6[DOI] 10.1111/tbj.12440.[PMID] 26136182.
1 citations·PubMed·Publisher's Site
2014
Appropriateness of breast cancer care: a changing landscape focusing on proper utilization of resources and patients' choices.
The breast journal.20(1):1-2[DOI] 10.1111/tbj.12224.[PMID] 24438062.
3 citations·PubMed·Publisher's Site
2014
Htert Gene Dna Methylation Index and Breast Invasive Ductal Carcinoma
Laboratory Investigation.94(1):66A-67A[DOI] .[PMID] .
PubMed·Publisher's Site
2013
Building access to quality breast pathology diagnosis across the globe: a call for action.
The breast journal.19(3):229-30[DOI] 10.1111/tbj.12120.[PMID] 23614362.
PubMed·Publisher's Site
2013
Focusing on breast cancer overdiagnosis and overtreatment: the promise of molecular medicine.
The breast journal.19(2):127-9[DOI] 10.1111/tbj.12095.[PMID] 23458217.
8 citations·PubMed·Publisher's Site
2013
Ultrasound guided fine needle aspiration biopsy: the new challenges and opportunities for cytopathologists.
Diagnostic cytopathology.41(12):1017-8[DOI] 10.1002/dc.23057.[PMID] 24167040.
3 citations·PubMed·Publisher's Site
2012
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.
The breast journal.18(4):303-11[DOI] 10.1111/j.1524-4741.2012.01264.x.[PMID] 22759093.
8 citations·PubMed·Publisher's Site
2012
Changing the term "breast tumor resembling the tall cell variant of papillary thyroid carcinoma" to "tall cell variant of papillary breast carcinoma".
Advances in anatomic pathology.19(2):108-10[DOI] 10.1097/PAP.0b013e318249d090.[PMID] 22313838.
26 citations·PubMed·Publisher's Site
2012
Characteristics of systemic diseases in the breast: clinical, imaging and pathologic features.
Women's health (London, England).8(5):593-9[DOI] 10.2217/whe.12.45.[PMID] 22934732.
PubMed·Publisher's Site
2012
Cytomorphology of male breast lesions: diagnostic pitfalls and clinical implications.
Diagnostic cytopathology.40(2):179-84[DOI] 10.1002/dc.21601.[PMID] 22246937.
10 citations·PubMed·Publisher's Site
2012
Expanded role of cytopathology in breast cancer diagnosis, therapy and research: the impact of fine needle aspiration biopsy and imprint cytology.
The breast journal.18(1):1-2[DOI] 10.1111/j.1524-4741.2011.01199.x.[PMID] 22226067.
4 citations·PubMed·Publisher's Site
2012
New insights from breast pathology: should we consider low grade DCIS NOT a cancer?
European journal of radiology.81 Suppl 1():S93-4[DOI] 10.1016/S0720-048X(12)70037-2.[PMID] 23083619.
3 citations·PubMed·Publisher's Site
2012
Rapid assessment breast clinic: how to offer the same day diagnosis?
The breast journal.18(2):101-2[DOI] 10.1111/j.1524-4741.2012.01225.x.[PMID] 22404049.
2 citations·PubMed·Publisher's Site
2012
Reproducibility of breast biopsy.
European journal of radiology.81 Suppl 1():S95-6[DOI] 10.1016/S0720-048X(12)70038-4.[PMID] 23083620.
PubMed·Publisher's Site
2012
The clinical significance of recognizing distinct morphologic features of systemic diseases on breast biopsies.
Advances in anatomic pathology.19(4):217-9[DOI] 10.1097/PAP.0b013e31825c6b58.[PMID] 22692284.
3 citations·PubMed·Publisher's Site
2012
The value of fine needle aspiration biopsy in the diagnosis and prognostic assessment of palpable breast lesions.
Diagnostic cytopathology.40(1):26-34[DOI] 10.1002/dc.21497.[PMID] 22180235.
36 citations·PubMed·Publisher's Site
2012
Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
Women's health (London, England).8(1):57-62[DOI] 10.2217/whe.11.88.[PMID] 22171775.
10 citations·PubMed·Publisher's Site
2011
Achieving excellence as a breast health educator at a global level: a new initiative of the World Society for Breast Health.
The breast journal.17(3):221-2[DOI] 10.1111/j.1524-4741.2011.01087.x.[PMID] 21545432.
PubMed·Publisher's Site
2011
Borderline breast lesions: diagnostic challenges and clinical implications.
Advances in anatomic pathology.18(3):190-8[DOI] 10.1097/PAP.0b013e31821698cc.[PMID] 21490436.
41 citations·PubMed·Publisher's Site
2011
Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative.
Breast (Edinburgh, Scotland).20 Suppl 2():S12-9[DOI] 10.1016/j.breast.2011.02.015.[PMID] 21388811.
44 citations·PubMed·Publisher's Site
2011
Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care.
Annals of clinical and laboratory science.41(1):8-13[DOI] .[PMID] 21325248.
14 citations·PubMed·Publisher's Site
2011
The use of fine-needle aspiration biopsy samples for the assessment of basal phenotype in triple negative breast cancer patients: a correlative study.
Diagnostic cytopathology.39(1):1-7[DOI] 10.1002/dc.21312.[PMID] 20091704.
4 citations·PubMed·Publisher's Site
2010
Evidence-based contributions of cytopathology to breast cancer diagnosis and research: how to sustain training and education in breast cytopathology?
The breast journal.16(5):457-9[DOI] 10.1111/j.1524-4741.2010.00972.x.[PMID] 21054643.
2 citations·PubMed·Publisher's Site
2010
How to restore public trust about breast cancer screening? An opportunity to reinforce the need for further advances in science and technology and access to care.
The breast journal.16(1):1-3[DOI] 10.1111/j.1524-4741.2009.00893.x.[PMID] 20465597.
1 citations·PubMed·Publisher's Site
2010
Is it time to retire the term of "in situ carcinoma" and use the term of "borderline breast disease?".
The breast journal.16(6):571-2[DOI] 10.1111/j.1524-4741.2010.01014.x.[PMID] 21070432.
5 citations·PubMed·Publisher's Site
2010
Lobular neoplasia displaying central necrosis: a potential diagnostic pitfall.
Pathology, research and practice.206(8):544-9[DOI] 10.1016/j.prp.2010.02.010.[PMID] 20359832.
3 citations·PubMed·Publisher's Site
2010
Study and management of breast disease.
The breast journal.16 Suppl 1():S1-[DOI] 10.1111/j.1524-4741.2010.00991.x.[PMID] 21050298.
PubMed·Publisher's Site
2009
"Early View": a new initiative of the Breast Journal.
The breast journal.15(3):221-2[DOI] 10.1111/j.1524-4741.2009.00734.x.[PMID] 19645774.
1 citations·PubMed·Publisher's Site
2009
Breast cancer risk assessment and follow-up management: is there a magic marker to identify high risk individuals?
The breast journal.15 Suppl 1():S1-[DOI] 10.1111/j.1524-4741.2009.00856.x.[PMID] 19775323.
PubMed·Publisher's Site
2009
Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
Diagnostic cytopathology.37(5):324-32[DOI] 10.1002/dc.21006.[PMID] 19191294.
39 citations·PubMed·Publisher's Site
2009
Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
Diagnostic cytopathology.37(3):184-90[DOI] 10.1002/dc.20982.[PMID] 19170172.
16 citations·PubMed·Publisher's Site
2009
Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Cancer prevention research (Philadelphia, Pa.).2(3):265-73[DOI] 10.1158/1940-6207.CAPR-08-0119.[PMID] 19223577.
13 citations·PubMed·Publisher's Site
2009
Implementation of the suggested guidelines for breast cancer risk, genetics, and risk assessment: the critical need for educating practicing physicians.
The breast journal.15(1):1-3[DOI] 10.1111/j.1524-4741.2008.00684.x.[PMID] 19141129.
2 citations·PubMed·Publisher's Site
2009
Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
Pathology international.59(6):405-9[DOI] 10.1111/j.1440-1827.2009.02385.x.[PMID] 19490472.
24 citations·PubMed·Publisher's Site
2009
Papillary thyroid carcinoma with metastasis to the frontal skull.
Diagnostic cytopathology.37(7):522-6[DOI] 10.1002/dc.21070.[PMID] 19459156.
6 citations·PubMed·Publisher's Site
2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.
The breast journal.15(1):4-16[DOI] 10.1111/j.1524-4741.2008.00665.x.[PMID] 19141130.
22 citations·PubMed·Publisher's Site
2009
The challenge of apocrine proliferations of the breast: a morphologic approach.
Pathology, research and practice.205(3):155-64[DOI] 10.1016/j.prp.2008.11.010.[PMID] 19147303.
16 citations·PubMed·Publisher's Site
2008
Breast pathology guideline implementation in low- and middle-income countries.
Cancer.113(8 Suppl):2297-304[DOI] 10.1002/cncr.23833.[PMID] 18837021.
37 citations·PubMed·Publisher's Site
2008
Crossing the borders: an international breast health educational initiative--a collaboration between the American Cancer Society and the University of Florida, Jacksonville.
The breast journal.14(1):1-2[DOI] 10.1111/j.1524-4741.2007.00541.x.[PMID] 18186861.
PubMed·Publisher's Site
2008
Integration of professionalism and volunteerism in building the foundation of the "International Institute of Breast Pathology" a worldwide collaboration.
The breast journal.14(2):125-7[DOI] 10.1111/j.1524-4741.2008.00565.x.[PMID] 18315689.
1 citations·PubMed·Publisher's Site
2008
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
Breast cancer research and treatment.112(2):327-33[DOI] .[PMID] 18097749.
20 citations·PubMed·Publisher's Site
2008
Significance of patient education and counseling in improving breast healthcare.
Women's health (London, England).4(6):551-5[DOI] 10.2217/17455057.4.6.551.[PMID] 19072456.
4 citations·PubMed·Publisher's Site
2008
Survivorship: a needed program for the continuity of care for breast cancer patients.
The breast journal.14(6):515-6[DOI] 10.1111/j.1524-4741.2008.00640.x.[PMID] 19053999.
3 citations·PubMed·Publisher's Site
2008
The knowledge about risk for breast cancer: the patients' right to know.
The breast journal.14(3):219-20[DOI] 10.1111/j.1524-4741.2008.00589.x.[PMID] 18476881.
2 citations·PubMed·Publisher's Site
2008
The National Accreditation Program for Breast Centers: quality improvement through interdisciplinary evaluation and management.
Bulletin of the American College of Surgeons.93(10):13-7[DOI] .[PMID] 19469362.
10 citations·PubMed·Publisher's Site
2007
Coming together to conquer the fight against breast cancer in countries of limited resources: the challenges and the opportunities.
The breast journal.13(3):223-5[DOI] .[PMID] 17461894.
4 citations·PubMed·Publisher's Site
2007
Diagnostic value of telomerase expression in breast fine-needle aspiration biopsies.
Diagnostic cytopathology.35(10):653-5[DOI] .[PMID] 17854082.
1 citations·PubMed·Publisher's Site
2007
The fine line between competency and quality performance in breast pathology: are we serving our patients right?
The breast journal.13(5):441-2[DOI] .[PMID] 17760663.
5 citations·PubMed·Publisher's Site
2007
Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients.
Diagnostic cytopathology.35(10):656-9[DOI] .[PMID] 17854083.
32 citations·PubMed·Publisher's Site
2006
An invitation to join the World Society of Breast Health.
The breast journal.12(5 Suppl 2):S123-[DOI] .[PMID] 16958989.
PubMed·Publisher's Site
2006
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
The breast journal.12 Suppl 1():S3-15[DOI] .[PMID] 16430397.
221 citations·PubMed·Publisher's Site
2006
Breast cancer in limited-resource countries: diagnosis and pathology.
The breast journal.12 Suppl 1():S27-37[DOI] .[PMID] 16430396.
67 citations·PubMed·Publisher's Site
2006
Breast cancer in resource-limited countries.
Women's health (London, England).2(6):797-800[DOI] 10.2217/17455057.2.6.797.[PMID] 19803996.
5 citations·PubMed·Publisher's Site
2006
Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy: a case report and review of the literature.
Diagnostic cytopathology.34(3):214-7[DOI] .[PMID] 16548002.
3 citations·PubMed·Publisher's Site
2006
Raising the bar: a plea for standardization and quality improvement in the practice of breast pathology.
The breast journal.12(5):409-12[DOI] .[PMID] 16958956.
17 citations·PubMed·Publisher's Site
2005
Core needle biopsy versus fine needle aspiration biopsy: are there similar sampling and diagnostic issues?
Clinics in laboratory medicine.25(4):679-88, vi[DOI] .[PMID] 16308086.
26 citations·PubMed·Publisher's Site
2005
Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
Clinics in laboratory medicine.25(4):827-43, viii[DOI] .[PMID] 16308095.
9 citations·PubMed·Publisher's Site
2005
Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
Clinics in laboratory medicine.25(4):713-31, vi[DOI] .[PMID] 16308088.
14 citations·PubMed·Publisher's Site
2005
Nipple fluid cytology.
Clinics in laboratory medicine.25(4):787-94, vii[DOI] .[PMID] 16308092.
8 citations·PubMed·Publisher's Site
2005
Prognostic/predictive factors in breast cancer.
Clinics in laboratory medicine.25(4):809-25, viii[DOI] .[PMID] 16308094.
34 citations·PubMed·Publisher's Site
2004
Female genital schistosomiasis: case report and review of the literature.
Southern medical journal.97(5):525-7[DOI] .[PMID] 15180032.
16 citations·PubMed·Publisher's Site
2004
Influencing the change: building blocks for integration of care in breast centers.
The breast journal.10(5):381-2[DOI] .[PMID] 15327488.
2 citations·PubMed·Publisher's Site
2004
Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, PA.
Human pathology.35(7):781-4[DOI] .[PMID] 15257539.
23 citations·PubMed·Publisher's Site
2004
Report of the Working Groups on Breast MRI: report of the Breast Cancer Staging Group.
The breast journal.10 Suppl 2():S3-8[DOI] .[PMID] 15330873.
1 citations·PubMed·Publisher's Site
2004
Stromal infiltration as a predictor of tumor invasion in breast fine-needle aspiration biopsy.
Diagnostic cytopathology.30(3):182-6[DOI] .[PMID] 14986299.
10 citations·PubMed·Publisher's Site
2003
Core needle biopsy versus fine-needle aspiration biopsy: are there similar sampling and diagnostic issues?
The breast journal.9(3):145-6[DOI] .[PMID] 12752620.
3 citations·PubMed·Publisher's Site
2003
Diagnosis of breast cancer in countries with limited resources.
The breast journal.9 Suppl 2():S60-6[DOI] .[PMID] 12713498.
20 citations·PubMed·Publisher's Site
2003
Implementation of a minimally invasive breast biopsy program in countries with limited resources.
The breast journal.9 Suppl 2():S81-5[DOI] .[PMID] 12713501.
18 citations·PubMed·Publisher's Site
2003
Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Diagnostic cytopathology.28(6):329-34[DOI] .[PMID] 12768640.
55 citations·PubMed·Publisher's Site
2003
The expanding role of pathologists in the diagnosis and management of breast cancer: Worldwide Excellence in Breast Pathology Program.
The breast journal.9 Suppl 2():S94-7[DOI] .[PMID] 12713504.
13 citations·PubMed·Publisher's Site
2003
Why most women with breast cancer still undergo mastectomy.
The breast journal.9(2):69-70[DOI] .[PMID] 12603376.
10 citations·PubMed·Publisher's Site
2002
The clinical significance of recognizing distinct morphologic and biologic features of hereditary breast cancer.
The breast journal.8(2):69-[DOI] .[PMID] 11896749.
2 citations·PubMed·Publisher's Site
2001
Expanding role of breast cytopathology as a risk predictor.
Advances in anatomic pathology.8(5):255-63[DOI] .[PMID] 11556533.
4 citations·PubMed·Publisher's Site
2001
Lipogranuloma.
The breast journal.7(5):363-4[DOI] .[PMID] 11906448.
PubMed·Publisher's Site
2001
Papillary carcinoma.
The breast journal.7(1):68-9[DOI] .[PMID] 11348420.
PubMed·Publisher's Site
2000
Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study.
Annals of clinical and laboratory science.30(3):259-65[DOI] .[PMID] 10945565.
94 citations·PubMed·Publisher's Site
2000
Assessment of prognostic factors in breast fine-needle aspirates.
American journal of clinical pathology.113(5 Suppl 1):S84-96[DOI] .[PMID] 11993712.
8 citations·PubMed·Publisher's Site
2000
Breast Cancer Awareness and the Power of Advocacy.
The breast journal.6(5):279-[DOI] .[PMID] 11348381.
1 citations·PubMed·Publisher's Site
2000
Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
Annals of clinical and laboratory science.30(1):33-40[DOI] .[PMID] 10678581.
7 citations·PubMed·Publisher's Site
2000
Response.
The breast journal.6(2):152-[DOI] .[PMID] 11348355.
PubMed·Publisher's Site
1999
Breast Health Education: Our Continuous Commitment.
The breast journal.5(5):287-[DOI] .[PMID] 11348303.
1 citations·PubMed·Publisher's Site
1999
Sampling of Nonpalpable Breast Lesions: A Plea for a Multidisciplinary Approach.
The breast journal.5(2):79-80[DOI] .[PMID] 11348264.
2 citations·PubMed·Publisher's Site
1999
The Missing Link: A "Pap Smear" For Early Breast Cancer Detection and Prevention.
The breast journal.5(1):1-2[DOI] .[PMID] 11348248.
1 citations·PubMed·Publisher's Site
1998
Automation in cytology: a survey conducted by the New Technology Task Force, Papanicolaou Society of Cytopathology.
Diagnostic cytopathology.18(1):47-55[DOI] .[PMID] 9451558.
3 citations·PubMed·Publisher's Site
1998
Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Annals of clinical and laboratory science.28(6):315-23[DOI] .[PMID] 9846198.
2 citations·PubMed·Publisher's Site
1998
Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium.
Annals of clinical and laboratory science.28(3):138-43[DOI] .[PMID] 9646853.
16 citations·PubMed·Publisher's Site
1998
Nuclear grooves in fine-needle aspiration biopsies of breast lesions: do they have any significance?
Diagnostic cytopathology.18(5):333-7[DOI] .[PMID] 9582567.
3 citations·PubMed·Publisher's Site
1998
Reproducibility of LSI HER-2/neu SpectrumOrange and CEP 17 SpectrumGreen Dual Color deoxyribonucleic acid probe kit. For enumeration of gene amplification in paraffin-embedded specimens: a multicenter clinical validation study.
Annals of clinical and laboratory science.28(4):215-23[DOI] .[PMID] 9715348.
21 citations·PubMed·Publisher's Site
1997
Fat embolism with the use of intraosseous infusion during cardiopulmonary resuscitation.
The American journal of the medical sciences.314(2):73-9[DOI] .[PMID] 9258208.
25 citations·PubMed·Publisher's Site
1997
The prognostic value of HER-2/neu oncogene in cervical cancer.
Annals of clinical and laboratory science.27(6):396-401[DOI] .[PMID] 9433536.
24 citations·PubMed·Publisher's Site
1997
Why women still die from cervical cancer.
The Journal of the Florida Medical Association.84(6):379-83[DOI] .[PMID] 9379163.
3 citations·PubMed·Publisher's Site
1996
Altered expression of alpha-smooth muscle isoactin in Hirschsprung's disease.
Archives of pathology & laboratory medicine.120(3):270-4[DOI] .[PMID] 8629903.
12 citations·PubMed·Publisher's Site
1996
Breast health. Challenges and promises.
The Journal of the Florida Medical Association.83(7):459-65[DOI] .[PMID] 8824086.
1 citations·PubMed·Publisher's Site
1995
Application of immunostaining for muscle specific actin in detection of myoepithelial cells in breast fine-needle aspirates.
Diagnostic cytopathology.13(1):71-4[DOI] .[PMID] 7587880.
15 citations·PubMed·Publisher's Site
1995
Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
Surgical oncology clinics of North America.4(4):601-32[DOI] .[PMID] 8535901.
7 citations·PubMed·Publisher's Site
1995
Prognostic factors in breast cancer: use of cytologic preparations.
Diagnostic cytopathology.13(5):388-95[DOI] .[PMID] 8834313.
21 citations·PubMed·Publisher's Site
1994
Prognostic and diagnostic implications of estrogen and progesterone receptor assays in cytology.
Diagnostic cytopathology.10(3):263-7[DOI] .[PMID] 8050334.
11 citations·PubMed·Publisher's Site
1994
Standardization of immunobioassays as surrogate endpoints.
Journal of cellular biochemistry. Supplement.19():28-35[DOI] .[PMID] 7823602.
7 citations·PubMed·Publisher's Site
1994
Unsuspected metastatic renal cell carcinoma diagnosed by fine needle aspiration biopsy. A report of four cases with immunocytochemical contributions.
Acta cytologica.38(4):554-61[DOI] .[PMID] 8042422.
12 citations·PubMed·Publisher's Site
1993
Cytology of malignant schwannoma metastatic to the lung. Report of a case with diagnosis by fine needle aspiration biopsy.
Acta cytologica.37(3):409-12[DOI] .[PMID] 8388612.
14 citations·PubMed·Publisher's Site
1993
Ductal carcinoma in situ of the breast.
Surgery, gynecology & obstetrics.177(4):425-40[DOI] .[PMID] 8211592.
28 citations·PubMed·Publisher's Site
1993
Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study.
Cancer.72(2):511-8[DOI] .[PMID] 8319181.
38 citations·PubMed·Publisher's Site
1992
Diagnosis of tuberculosis of bone and soft tissue by fine-needle aspiration biopsy.
Diagnostic cytopathology.8(5):451-5[DOI] .[PMID] 1396023.
42 citations·PubMed·Publisher's Site
1992
Estrogen and progesterone receptors in cytology: a comprehensive review.
Diagnostic cytopathology.8(5):475-91[DOI] .[PMID] 1396026.
61 citations·PubMed·Publisher's Site
1992
Expression of steroid hormone receptors in benign hepatic tumors. An immunocytochemical study.
Archives of pathology & laboratory medicine.116(12):1355-9[DOI] .[PMID] 1333749.
13 citations·PubMed·Publisher's Site
1992
Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas.
Cancer.70(8):2109-14[DOI] .[PMID] 1327487.
23 citations·PubMed·Publisher's Site
1992
Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Cancer detection and prevention.16(4):225-35[DOI] .[PMID] 1281040.
13 citations·PubMed·Publisher's Site
1992
Use of monoclonal antibody for assessment of estrogen and progesterone receptors in malignant effusions.
Diagnostic cytopathology.8(2):161-6[DOI] .[PMID] 1568413.
9 citations·PubMed·Publisher's Site
1991
Application of estrogen receptor immunocytochemical assay to aspirates from mammographically guided fine needle biopsy of nonpalpable breast lesions.
Southern medical journal.84(7):857-61[DOI] .[PMID] 1712514.
10 citations·PubMed·Publisher's Site
1991
Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates.
Diagnostic cytopathology.7(6):581-90[DOI] .[PMID] 1769286.
57 citations·PubMed·Publisher's Site
1991
Fine needle aspiration cytology of papillary endometrioid carcinoma of the prostate. The grooved nucleus as a cytologic marker.
Acta cytologica.35(4):451-5[DOI] .[PMID] 1718114.
12 citations·PubMed·Publisher's Site
1991
Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates.
American journal of clinical pathology.95(1):35-40[DOI] .[PMID] 1987750.
5 citations·PubMed·Publisher's Site
1991
Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization.
Southern medical journal.84(2):235-6[DOI] .[PMID] 1703667.
22 citations·PubMed·Publisher's Site
1991
Immunocytochemical analysis of progesterone receptors in breast cancer.
American journal of clinical pathology.96(1):59-63[DOI] .[PMID] 1712544.
21 citations·PubMed·Publisher's Site
1991
Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival.
The American journal of pathology.139(2):245-50[DOI] .[PMID] 1714241.
192 citations·PubMed·Publisher's Site
1990
Extragenital granuloma inguinale mimicking a soft-tissue neoplasm: a case report and review of the literature.
Human pathology.21(5):559-61[DOI] .[PMID] 1692564.
5 citations·PubMed·Publisher's Site
1990
Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.3(6):724-8[DOI] .[PMID] 1702213.
25 citations·PubMed·Publisher's Site
1990
Potential value of hormone receptor assay in carcinoma in situ of breast.
American journal of clinical pathology.94(5):533-7[DOI] .[PMID] 2173395.
62 citations·PubMed·Publisher's Site
1990
Potential value of immunoperoxidase technique in assessment of genital herpes.
The Journal of the Florida Medical Association.77(5):516-9[DOI] .[PMID] 2112586.
PubMed·Publisher's Site
1990
Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalpable breast lesions.
Cancer.66(7):1480-7[DOI] .[PMID] 2169989.
118 citations·PubMed·Publisher's Site
1989
The potential value of mammographically guided fine-needle aspiration biopsy of nonpalpable breast lesions.
The American surgeon.55(4):226-31[DOI] .[PMID] 2705686.
6 citations·PubMed·Publisher's Site
1989
Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
Archives of pathology & laboratory medicine.113(1):26-30[DOI] .[PMID] 2462858.
61 citations·PubMed·Publisher's Site
1988
Fine needle aspiration cytology of chondroid syringoma. Report of a case.
Acta cytologica.32(4):482-4[DOI] .[PMID] 2456654.
25 citations·PubMed·Publisher's Site
1988
The potential value of imprint cytology in cytochemical localization of steroid hormone receptors in ovarian cancer.
Diagnostic cytopathology.4(1):42-7[DOI] .[PMID] 3288456.
4 citations·PubMed·Publisher's Site
1988
Use of monoclonal antibodies in immunocytochemical localization of estrogen receptors in ovarian cancer.
Cancer detection and prevention.12(1-6):283-90[DOI] .[PMID] 3052833.
1 citations·PubMed·Publisher's Site

Office Information

Academic Office
ma
655 West 8th Street, C504
Jacksonville, FL 32209
(904) 244-4387
 shahla.masood@jax.ufl.edu
Executive Assistant
 Stephanie Crawford
(904) 244-7815
stephanie.crawford@jax.ufl.edu
Administrative Manager
 Karen Earick
(904) 244-6069
Karen.Earick@jax.ufl.edu
GME Office
1st Floor, Clinical Center
655 West 8th Street, C504
Jacksonville, FL 32209
Phone: (904) 244-4889
Fax: (904) 244-4060
 shahla.masood@jax.ufl.edu
Program Administrator
 Rebel Jones
(904) 244-4889
rebel.jones@jax.ufl.edu
Medical Student Office
1st Floor, Clinical Center
655 West 8th Street, C504
Jacksonville, FL 32209
Phone: (904) 244-4889
Fax: (904) 244-4060
 shahla.masood@jax.ufl.edu
Clerkship Coordinator
 Rebel Jones
(904) 244-4889
rebel.jones@jax.ufl.edu

Education

Medical Degree
1973 · Shiraz University, Shiraz, Iran
Pathology - Anatomic and Clinical Residency
1975 · Jacksonville Health Education Programs (JHEP), Jacksonville, FL, USA
Cytopathology Fellowship
1977 · Jacksonville Health Education Programs (JHEP), Jacksonville, FL, USA

News

February 3, 2023
Shahla Masood, MD: A journey in medicine and the pursuit of freedom
June 11, 2021
Can Breast Cancer Occur in Men?
October 20, 2020
The 411 on Breast Health
June 8, 2020
Spotlight on pathology and laboratory medicine
March 3, 2020
A quarter century of breast health expertise

Media Coverage

September 18, 2022
Dr. Shahla Masood: Ongoing disparities in outcomes for breast cancer patients
Florida Times-Union
October 19, 2021
UF Health to host free virtual forum Thursday to inform public about breast health
Action News
October 5, 2021
Expert shares breast cancer insight in wake of Florida first lady's diagnosis
News4Jax (WJXT)
October 17, 2020
Understanding the impact of breast cancer
News4Jax (WJXT)
October 17, 2019
Jacksonville breast cancer symposium empowers patients to ask questions
News4Jax (WJXT)

Multimedia

January 14, 2020
Second Opinion - UF Health Breast Center - Jacksonville
February 15, 2019
Same Day Breast Assessment
June 8, 2016
Does Nipple Discharge Indicate Breast Cancer?
June 8, 2016
Breast Cancer in Men
June 7, 2016
Breast Cancer Risk Factors